Sorry, you need to enable JavaScript to visit this website.
Search
March 11, 2022

CDC-Abt Study Shows Pfizer Vaccine Is Moderately Effective for Children

Body

More than 300 news organizations, including CBS and Forbes, quoted Abt’s Lauren Olsho explaining the benefits of our PROTECT study for the CDC, which gathers and tests nasal swabs weekly from children, regardless of whether they had COVID-19 symptoms. “Without regular weekly testing you will miss many infections, particularly for kids, who often have mild symptoms,” said Olsho, the study’s principal investigator. Other pediatric vaccine studies captured only symptomatic cases, and with more home testing, studies like Abt’s are needed for a comprehensive view of vaccine effectiveness, she noted.

Read More

Association for Public Policy Analysis & Management (APPAM) 2024 Fall Research Conference

Experts from Abt Global will be presenting at the Association for Public Policy Analysis & Management (APPAM) 2024 Fall Research Conference.

Learn More
Event

The Alliance for LGBTQI+ Inclusive Development presents The Impact of Geopolitical Shifts on Inclusive Development

Abt Global is hosting the upcoming hybrid LGBTQI+ Inclusive Development Summit on November 19, 2024.

Learn More
Event

The Alliance for LGBTQI+ Inclusive Development presents The Impact of Geopolitical Shifts on Inclusive Development

Abt Global is hosting the upcoming hybrid LGBTQI+ Inclusive Development Summit on November 19, 2024.

Learn More
Event

Bridging the Data Gap: Uncovering Long-Term Outcomes of Workforce Development Programs

Abt’s long-term studies of career pathways and apprenticeship programs will provide critical new information on sustainability of participants’ earnings gains.

Learn More
Project